Syk inhibitor PRT062607 HCL, Purity ≥98%

Cat. No.: X24-06-ZQ512

Syk inhibitor PRT062607 HCL, Purity ≥98%

Synonym: 1370261-97-4; Syk inhibitor; P505-15; PRT2607; PRT-2607; PRT 2607; PRT-062607; PRT 062607; P505-15; BIIB057

  • MDL: MFCD25976708
  • CAS Number: 1370261-97-4
  • Compound CID: 56948527
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
PRT062607 HCL blocks the activity of spleen tyrosine kinase (Syk), a key protein involved in the signaling pathways of various immune cells and implicated in the pathogenesis of autoimmune diseases and certain cancers. It targets FGR, MLK1, c-Src, FLT3, LCK, Lyn, PAK5, Syk, and YES.
Molecular Weight
429.91
Molecular Formula
C19H24ClN9O
Targets
FGR: 81 nM; MLK1: 88 nM; c-Src: 244 nM; FLT3: 139 nM; LCK: 249 nM; Lyn: 192 nM; PAK5: 166 nM; Syk: 1 nM; YES: 123 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
PRT062607 HCL is utilized in the study of Syk-mediated signaling pathways involved in immune cell activation and inflammatory responses.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0